Momenta Pharmaceuticals, Inc. (MNTA)

[biotech_researcher]

Cash and cash equivalents

$
273,451


$
237,179

Accounts receivable


7,262



1,305

Inventory


969



419

Other current assets


7,705



6,043













Total current assets


289,387



244,946




Restricted cash


11,326



11,357

Property and equipment, net


178,602



108,777

Intangible and other assets, net


4,377



5,814













Total assets

$
483,692


$
370,894













LIABILITIES AND STOCKHOLDERS’ EQUITY








Current liabilities:








Accounts payable

$
10,680


$
11,363

Current portion of long-term debt


—



4,200

Current portion of long-term facility lease obligation


4,971



—

Accrued compensation and benefits


14,427



12,778

Accrued product development expenses


13,793



16,740

Other accrued expenses


10,098



8,977

Current portion of deferred executive compensation


—



2,511

Current portion of deferred revenue


2,090



472

Other current liabilities


16,807



15,136













Total current liabilities


72,866



72,1



—










Other long-term debt


—



4,900










Long-term facility lease obligation


166,277



99,412










Other long-term liabilities


8,331



8,580










Deferred revenue


135



308